- Studies of antibodies and T cells in patients with Rheumatic disease.
- Novel drug targets in patients with Rheumatic diseases; a role for IL-4R signaling.
- Therapeutic antibody treatment for Cancer; a role for myeloid-derived suppressor cells and IL-4R signaling.
- Custom CRISPR/Cas9 screens to identify drug targets in inflammatory diseases and Cancer.
Outline CRISPR screens: